These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23176882)

  • 1. Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy.
    Greenhawt MJ; Spergel JM; Rank MA; Green TD; Mansoor D; Sharma H; Bird JA; Chang JE; Parikh DS; Teich E; Kelso JM; Sanders GM
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):426-30. PubMed ID: 23176882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of influenza vaccine administration in egg-allergic patients.
    Chung EY; Huang L; Schneider L
    Pediatrics; 2010 May; 125(5):e1024-30. PubMed ID: 20368312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
    Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SAFETY OF INFLUENZA VACCINATION IN CHILDREN WITH SEVERE ALLERGY TO HEN'S EGGS: A PROSPECTIVE CASE SERIES STUDY].
    Shimizu M; Imai T; Yamazaki S; Yagawa A; Miyazawa T; Nakamura T; Hojo N; Ishikawa R; Kamiya T; Itahashi K
    Arerugi; 2016 Mar; 65(2):128-33. PubMed ID: 27086959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy.
    Esposito S; Gasparini C; Martelli A; Zenga A; Tremolati E; Varin E; Marseglia GL; Fiocchi A; Principi N
    Vaccine; 2008 Aug; 26(36):4664-8. PubMed ID: 18639601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the safety of influenza vaccine in egg-allergic individuals.
    Greenhawt MJ
    Pediatr Ann; 2013 Jul; 42(7):122-7. PubMed ID: 23805959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.
    Vesikari T; Block SL; Guerra F; Lattanzi M; Holmes S; Izu A; Gaitatzis N; Hilbert AK; Groth N
    Pediatr Infect Dis J; 2012 May; 31(5):494-500. PubMed ID: 22301476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe administration of seasonal influenza vaccine to children with egg allergy of all severities.
    Howe LE; Conlon AS; Greenhawt MJ; Sanders GM
    Ann Allergy Asthma Immunol; 2011 May; 106(5):446-7. PubMed ID: 21530882
    [No Abstract]   [Full Text] [Related]  

  • 10. Administering influenza vaccine to egg-allergic persons.
    Kelso JM
    Expert Rev Vaccines; 2014 Aug; 13(8):1049-57. PubMed ID: 24962036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of live attenuated influenza vaccine in atopic children with egg allergy.
    Turner PJ; Southern J; Andrews NJ; Miller E; Erlewyn-Lajeunesse M;
    J Allergy Clin Immunol; 2015 Aug; 136(2):376-81. PubMed ID: 25684279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician compliance with updated practice parameters for influenza vaccination in individuals with egg allergies.
    Greenhawt M; Wang J
    J Allergy Clin Immunol Pract; 2013; 1(6):602-7. PubMed ID: 24565707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on influenza vaccination in patients with egg allergy.
    Gruenberg DA; Shaker MS
    Curr Opin Pediatr; 2011 Oct; 23(5):566-72. PubMed ID: 21881505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.
    Englund JA; Walter E; Black S; Blatter M; Nyberg J; Ruben FL; Decker MD;
    Pediatr Infect Dis J; 2010 Feb; 29(2):105-10. PubMed ID: 19934787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease.
    Schuler JE; King WJ; Dayneka NL; Rastelli L; Marquis E; Chad Z; Hui C
    Can J Public Health; 2011; 102(3):196-9. PubMed ID: 21714318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine-associated anaphylaxis.
    Nagao M; Fujisawa T; Ihara T; Kino Y
    J Allergy Clin Immunol; 2016 Mar; 137(3):861-7. PubMed ID: 26365388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.